These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 22828207

  • 1. Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study.
    Hyde Z, Flicker L, McCaul KA, Almeida OP, Hankey GJ, Chubb SA, Yeap BB.
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1319-29. PubMed ID: 22828207
    [Abstract] [Full Text] [Related]

  • 2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 3. Circulating steroid hormones and the risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.
    Chan YX, Alfonso H, Chubb SA, Handelsman DJ, Fegan PG, Hankey GJ, Golledge J, Flicker L, Yeap BB.
    Horm Cancer; 2017 Apr; 8(2):119-126. PubMed ID: 28233278
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
    Rossi E, Hung J, Beilby JP, Knuiman MW, Divitini ML, Bartholomew H.
    Ann Epidemiol; 2006 Mar; 16(3):206-12. PubMed ID: 16343942
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hormonal predictors of prostate cancer.
    Sofikerim M, Eskicorapci S, Oruç O, Ozen H.
    Urol Int; 2007 Mar; 79(1):13-8. PubMed ID: 17627161
    [Abstract] [Full Text] [Related]

  • 11. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.
    Eaton NE, Reeves GK, Appleby PN, Key TJ.
    Br J Cancer; 1999 Jun; 80(7):930-4. PubMed ID: 10362098
    [Abstract] [Full Text] [Related]

  • 12. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A, Gallina A, Briganti A, Zanni G, Suardi N, Capitanio U, Colombo R, Bertini R, Freschi M, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [Abstract] [Full Text] [Related]

  • 13. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
    Chan YX, Knuiman MW, Divitini ML, Brown SJ, Walsh J, Yeap BB.
    Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
    [Abstract] [Full Text] [Related]

  • 14. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
    Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, Metter EJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
    [Abstract] [Full Text] [Related]

  • 18. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
    Guddat HM, Schnorr D, Dörner G, Stahl F, Rohde W.
    Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.